Chronic lymphocytic leukemia (CLL) is the most prevalent form of leukemia in adults, typically affecting those aged 65 years and older. While radiologic imaging is not considered as critical for initial diagnosis or during staging, it plays a crucial role… Read More
At Clinical Endpoints, we are a Site Management Organization (SMO) that is dedicated to revolutionizing neurology research to enhance the lives of individuals with neurological disorders. Our focus spans various conditions, including Alzheimer’s and Parkinson’s disease, as we seek innovative… Read More
Imaging is essential in hepatocellular carcinoma (HCC) clinical trials, guiding diagnosis and monitoring treatment efficacy. Among the most valuable tools are triphasic CT and/or MRI, which significantly improve diagnostic accuracy by differentiating liver tumors from surrounding tissues and assessing treatment… Read More
Medical imaging is integral to the evolution of breast cancer clinical trials providing crucial insights into tumor detection and treatment evaluation. Mammography and ultrasound are the standard imaging modalities for screening and initial diagnosis, MRI helps determine the extent of… Read More
Prostate cancer is the most common cancer among men and the second leading cause of cancer death after lung cancer. Advances in imaging techniques, particularly multiparametric magnetic resonance imaging (mpMRI) and prostate-specific membrane antigen (PSMA) PET/CT (that Imaging Endpoints helped… Read More
Featured Webinar:
Radiologic Analysis of COVID-19 Infection
June 23, 2020
